Analyst maps out road ahead for Phibro after IPO: 'It can become the Pfizer of the animal health and nutrition space'
Joint ventures and license deals are the key to growth for US trace mineral and medicinal feed additive firm, Phibro Animal Health, says an analyst evaluating prospects for the group after its IPO mid-April.